{"product_id":"point-of-care-molecular-diagnostics-market-by-product-and-service-assays-kits-instruments-analyzers-software-services-by-technology-rt-pcr-inaat-other-technologies-by-application-respiratory-diseases-sexually-transmitted-diseases-hospi","title":"Point of Care Molecular Diagnostics Market: By Product and Service (Assays \u0026 Kits, Instruments \u0026 Analyzers, Software \u0026 Services), By Technology (RT-PCR, INAAT, Other Technologies), By Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospi","description":"\u003cp\u003ePoint of Care Molecular Diagnostics Market: By Product and Service (Assays \u0026amp; Kits, Instruments \u0026amp; Analyzers, Software \u0026amp; Services), By Technology (RT-PCR, INAAT, Other Technologies), By Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infections, Cancer, Hepatitis, Gastrointestinal Disorders, Other Applications), By End-User (Physicians’ Offices, Hospitals \u0026amp; ICUs, Research Institutes, Other End Users) And Region – Global Analysis of Market Size, Share \u0026amp; Trends For 2019–2021 And Forecasts To 2031\u003cbr\u003e\nPoint of Care Molecular Diagnostics Market: By Product and Service (Assays \u0026amp; Kits, Instruments \u0026amp; Analyzers, Software \u0026amp; Services), By Technology (RT-PCR, INAAT, Other Technologies), By Application (Respiratory Diseases, Sexually Transmitted Diseases, Hospital-acquired Infections, Cancer, Hepatitis, Gastrointestinal Disorders, Other Applications), By End-User (Physicians’ Offices, Hospitals \u0026amp; ICUs, Research Institutes, Other End Users) And Region – Global Analysis of Market Size, Share \u0026amp; Trends For 2019–2021 And Forecasts To 2031\u003c\/p\u003e\n\n\u003cp\u003ePRODUCT OVERVIEW\u003c\/p\u003e\n\n\u003cp\u003eMolecular diagnostic testing blends laboratory testing with molecular biology precision, revolutionizing how clinical and public health laboratories explore human, viral, and microbial genomes, genes, and the products they encode. Various conventional tests have been replaced by molecular diagnostic assays in many areas of laboratory medicine, including infectious diseases, oncology, clinical genetics, and clinical chemistry. Furthermore, advances in molecular diagnostic testing will continue to improve the precision and speed with which we can detect microbial infections or study a patient's genes, and it will become an increasingly important part of patient-tailored interventions and medicines.\u003c\/p\u003e\n\n\u003cp\u003eMARKET HIGHLIGHTS\u003cbr\u003e\nGlobal Point of Care Molecular Diagnostics Market is expected to register huge progress at a notable CAGR of 9.2% by 2031Global Point of Care Molecular Diagnostics Market to surpass USD 7.6 billion by 2031 from USD 3.2 billion in 2021 at a CAGR of 9.2% in the coming years, i.e., 2021-2031. The Point of Care Molecular Diagnostics Market is being driven by factors such as the rising prevalence of infectious diseases \u0026amp; cancer, a growing focus on decentralized diagnostics, and increased R\u0026amp;D investment. Furthermore, growing awareness of the early diagnosis of infectious diseases and increased usage of point-of-care diagnostic tests are other drivers driving market expansion.GLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET: SEGMENTS\u003cbr\u003e\nAssays \u0026amp; Kits segment is predicted to lead the market over the forecast period with maximum CAGR\u003c\/p\u003e\n\n\u003cp\u003eBy Product and Service, the Global Point of Care Molecular Diagnostics Market is divided into Assays \u0026amp; Kits, Instruments \u0026amp; Analyzers, and Software \u0026amp; Services. The sector of assays and kits held the greatest share of the market. The market expansion of this sector is driven by frequent purchases of these products due to their regular use. Today, a diverse range of kits and assays are available for monitoring and diagnosing a wide range of disorders.\u003c\/p\u003e\n\n\u003cp\u003eRT-PCR segment is expected to witness a higher share of the market in the near future\u003c\/p\u003e\n\n\u003cp\u003eBy Technology, the Global Point of Care Molecular Diagnostics Market is divided into RT-PCR, INAAT, and Other Technologies. The RT-PCR sector had the most market share. The expanding usage of RT-PCR in proteomics, COVID-19 testing, genomics, as well as the availability of portable, easy-to-use instruments, are the primary drivers of this market segment's growth.\u003c\/p\u003e\n\n\u003cp\u003eMARKET DYNAMICS\u003c\/p\u003e\n\n\u003cp\u003eDrivers\u003c\/p\u003e\n\n\u003cp\u003eGrowing number of cancer patients and individuals affected with infectious diseases across the globe is majorly boosting the market\u003c\/p\u003e\n\n\u003cp\u003eThe shift from centralized to decentralized owing to its simplicity, convenience, and other benefits is propelling the market growth\u003c\/p\u003e\n\n\u003cp\u003eRestraint\u003c\/p\u003e\n\n\u003cp\u003eInsufficient reimbursements are hampering the market growth of Global Point of Care Molecular Diagnostics\u003cbr\u003e\nGLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET:\u003cbr\u003e\nKey Players Abbott LaboratoriesCompany Overview, Business Strategy, Key Product Offerings, Financial Performance, Key Performance Indicators, Risk Analysis, Recent Development, Regional Presence, SWOT Analysis Bayer AG BioMerieux SA Bio-Rad Laboratories, Inc. Danaher Corporation F. Hoffmann-La Roche Ltd. Nova Biomedical OraSure Technologies, Inc. Qiagen Gmbh Sekisui Medical Co., Ltd. Zoetis Inc. Other Prominent PlayersGLOBAL POINT OF CARE MOLECULAR DIAGNOSTICS MARKET REPORT ALSO CONTAINS AN ANALYSIS ON:Global Point of Care Molecular Diagnostics Market Segments: By Product \u0026amp; ServiceAssays \u0026amp; KitsInstruments \u0026amp; AnalyzersSoftware \u0026amp; Services By TechnologyRT-PCRINAATOther Technologies By ApplicationRespiratory DiseasesSexually Transmitted DiseasesHospital-acquired InfectionsCancerHepatitisGastrointestinal DisordersOther Applications By End-UserPhysicians’ OfficesHospitals \u0026amp; ICUsResearch InstitutesOther End Users Global Point of Care Molecular Diagnostics Market Dynamics Global Point of Care Molecular Diagnostics Market Size Supply \u0026amp; Demand Current Trends\/Issues\/Challenges Competition \u0026amp; Companies Involved in the Market Value Chain of the Market Market Drivers and RestraintsReasons to Purchase this Report  Qualitative and quantitative analysis of the market based on segmentation involving both economic as well as non-economic factors  Provision of market value (USD Billion) data for each segment and sub-segment  Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market  Analysis by geography highlighting the consumption of the product\/service in the region as well as indicating the factors that are affecting the market within each region  Competitive landscape which incorporates the market ranking of the major players, along with new service\/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled  Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players  The current as well as the future market outlook of the industry with respect to recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions  Includes in-depth analysis of the market of various perspectives through Porter’s five forces analysis  Provides insight into the market through Value Chain  Market dynamics scenario, along with growth opportunities of the market in the years to come  3-month post-sales analyst support. *Please Note: The report will be delivered in 4-5 business days upon order confirmation*\u003c\/p\u003e","brand":"Life Science","offers":[{"title":"May, 2023 \/ 468 Pages \/ MCW16229748","offer_id":47646997610802,"sku":null,"price":5940.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/www.hardmanwell.com\/products\/point-of-care-molecular-diagnostics-market-by-product-and-service-assays-kits-instruments-analyzers-software-services-by-technology-rt-pcr-inaat-other-technologies-by-application-respiratory-diseases-sexually-transmitted-diseases-hospi","provider":"HARDMAN AND WELL MANAGEMENT CONSULTANCIES L.L.C","version":"1.0","type":"link"}